PHILADELPHIA, April 23, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the launch of its Partner Ecosystem for the life sciences market, a new initiative aimed at enabling access to the company's life sciences information through application-specific solutions developed with third-party partners.
Through the Partner Ecosystem, third party developers take advantage of the Thomson Reuters Cortellis open architecture to access the company's content and technology, creating value-add custom solutions that meet the needs of their customers. These solutions can include Thomson Reuters market leading ontologies, biological target information and other critical information that supports pharmaceutical business development and competitive intelligence projects.
The flexible approach to information delivery enables companies to integrate Thomson Reuters trusted drug pipeline data seamlessly into a user's workflow, delivering the right information at the point of need so users can make informed decisions more quickly. In addition, partners gain access to the Cortellis Developer Center, a forum where client and third party developers collaborate to share ideas, best practices, and discuss new applications as well as obtain technical support from Thomson Reuters technology and content experts.
"We understand the important role our partners play in working with us to support the success of our mutual customers. The Partner Ecosystem is a step toward providing the infrastructure and collaboration environment necessary to develop solutions that enable the drug R&D process," said Jon Brett-Harris, executive vice president at Thomson Reuters. "The Partner Ecosystem, alongside our portfolio of other advanced solutions, provides the life sciences industry
|SOURCE Thomson Reuters|
Copyright©2010 PR Newswire.
All rights reserved